23andMe Gets Snubbed As Wirecutter Ranks Ancestry Testing Services

Anne Wojcicki, the CEO of 23andMe. Image by Getty

By Ari Feldman September 5, 2017

The Wirecutter, a popular product recommendation site, recently offered reviews about the leading genetic ancestry testing services. The big surprise? 23andMe, the popular genomics company, was not listed as a top pick. Instead, the site ranked Ancestry.com and Family Tree DNA as the best picks.

The Wirecutter’s decision not to recommend 23andMe had to do with how the company collects biomedical data about its customers. The basic testing kit from 23andMe gives results about your ancestry and costs $100. According to the Wirecutter’s research, however, 23andMe tests for both your ancestry and your genetic health when you send them your saliva. Though receiving the health results — indicating whether you may have a hereditary risk for a particular disease, for example — costs an additional $100, 23andMe can sell your biomedical data if you haven’t purchased the health test.

“The problem is that if you’ve paid for just the ancestry test and signed the consent form, you’ve granted access not just to your ancestry data but to your biomedical data, which you’d have no reasonable way of knowing was even obtained,” the Wirecutter wrote.

A spokeswoman for 23andMe said that it performs both the ancestry and health tests when they receive your saliva as a convenience — so that if you decide later you want the health test in addition to the ancestry test, they already have the results on file.

23andMe recently posted a discredited theory about the genetic heritage of Ashekenazi Jews on its website, telling some users that they may descended from a semi-nomadic tribe from Central Asia.

Contact Ari Feldman at [email protected] or on Twitter @aefeldman.

Ari Feldman is a staff writer at the Forward. He covers Jewish religious organizations, synagogue life, anti-Semitism and the Orthodox world. If you have any tips, you can email him at [email protected]. Follow him on Twitter @aefeldman.

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

The coming year promises to be filled with more complex and historic developments. We are entering an era where independent, fact-based Jewish journalism will be more important than ever. We need to be ready for whatever 2025 will bring, and with your help, we can be.

We’ve set a goal to raise $260,000 by December 31. That’s an ambitious goal, but one that will give us the resources we need to invest in the high quality news, opinion, analysis and cultural coverage that isn’t available anywhere else.

If you feel inspired to make an impact, now is the time to give something back. Join us as a member at your most generous level.

— Rachel Fishman Feddersen, Publisher and CEO